AVE 33.3% 0.4¢ avecho biotechnology limited

Ann: Phosphagenics Pain Program Update , page-50

  1. 5,894 Posts.
    lightbulb Created with Sketch. 360
    "I think any thought of self-financing Phase 3 have evaporated. A deal will be struck ahead of Phase 3 trials."

    Jev it may be this very reason that the trial has been varied? To demonstrate efficacy to potential big check signers?

    Why spend $20mill when you can do it for $5mill?
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
0.001(33.3%)
Mkt cap ! $12.67M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $485 136.4K

Buyers (Bids)

No. Vol. Price($)
1 5624 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 17983217 9
View Market Depth
Last trade - 14.10pm 24/12/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.